Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide.

Biotechnology

Alpha Tau Medical

Uzi Sofer

Avia Berkowitz

Uri Salomon

S. Morry Blumenfeld

Rebecca (Feldman) Becker

Peter Melnyk

Eliran Moshe - אלירן משה

Yona Keisari

Ofer Magen

Yaniv Sagie

Rebecca Becker

Amnon Gat

Ronen Segal

Robert Den

Raphi Levy

Itzhak Kelson

The Leadership Team at Alpha Tau Medical is responsible for strategic direction and oversight of the company's operations, ensuring that the development and commercialization of Alpha DaRT technology align with regulatory standards and market needs. This team, composed of key executives, collaborates to define company objectives, drive innovation, manage resources, and facilitate clinical trials to enhance the effectiveness of cancer treatment options worldwide.

Leadership Team

Research and Development

Engineering and Product Management

Leadership Team

About

Team members

Other teams at Alpha Tau Medical

Research and Development

Engineering and Product Management